Other Species / Isoforms
  FRAT1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S88-p
VPADKARsPAVPLLL
0 3
FRAT1 (human) VPADKARsPAVPLLL S88-p
FRAT1 (mouse) LPADKTGTPARRLLR T84
S138-p
AELATGPsALSPLPP
0 1
FRAT1 (human) AELATGPsALSPLPP S138-p
FRAT1 (mouse) AEISPGASALPQQPG S134
S188-p
RLQQRRGsQPETRTG
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, inhibited
  • protein degradation
Effects on Biological Processes:
  • transcription, inhibited
Kinase, in vitro:
  • GSK3B (human)
  • PKACA (human)
  • PKCA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • bryostatin_1
  • cAMP_analog
  • colforsin
  • lithium
  • norepinephrine
  • okadaic_acid
  • phorbol_ester
  • SB415286
FRAT1 (human) RLQQRRGsQPETRTG S188-p
FRAT1 (mouse) RLQQRRGSQPETRTG S181
K214-ub
VLSGNLIkEAVRRLH
0 1
FRAT1 (human) VLSGNLIkEAVRRLH K214-ub
FRAT1 (mouse) VLSGNLIKEAVRRLH K208
S241
RPLLGPLSAPVHEPP
0 2
FRAT1 (human) RPLLGPLSAPVHEPP S241
FRAT1 (mouse) HPFLGPLsAPVHEPP S235-p
S249-p
APVHEPPsPRSPRAA
0 5
FRAT1 (human) APVHEPPsPRSPRAA S249-p
FRAT1 (mouse) APVHEPPsPGsPRAA S243-p
S252
HEPPsPRSPRAACSD
0 4
FRAT1 (human) HEPPsPRSPRAACSD S252
FRAT1 (mouse) HEPPsPGsPRAACsD S246-p
S258
RSPRAACSDPGASGR
0 1
FRAT1 (human) RSPRAACSDPGASGR S258
FRAT1 (mouse) GsPRAACsDPGAFMG S252-p
S279-p
DGVLVPGs_______
0 1
FRAT1 (human) DGVLVPGs_______ S279-p
FRAT1 (mouse) DDLLVPGS_______ S274